Get started
Author

Mark Prentice

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
2019 · H.J. Boyle, S. Alibhai, et al. · European Journal of Cancer · 236
PDF
Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis
2025 · Alexander B.C.D. Ng, Aqua Asif, et al. · JAMA · 82
PDF
Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer
2025 · K. Fizazi, K. Fizazi, et al. · Annals of Oncology · 48
PDF
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
2025 · Silke Gillessen, Silke Gillessen, et al. · The Lancet Oncology · 26
PDF
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5
Pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with docetaxel-pretreated, metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort E.
2024 · Marinela Augustin, Brigitte Laguerre, et al. · Journal of Clinical Oncology · 2
PDF
Patterns of therapy in pelvic lymph node positive prostate cancer in Europe and Asia: A real-world data analysis
2018 · M. Prentice, S. Mpima, et al. · Annals of Oncology · 2
Brachytherapy in prostate cancer: techniques and clinical outcomes
2018 · Mark Prentice, Wenlong Nei, et al. · Trends in Urology & Men s Health · 2
PDF
Brass Mesh Bolus versus Conventional Vaseline Bolus for Chest Wall Radiotherapy. A Single Plan Solution?
2015 · A. Ward, V. Wolstenholme, et al. · Clinical Oncology · 2
Prospective real world data evaluation of clinical outcomes in metastatic hormone sensitive prostate cancer (MHSPC) patients treated as part of triplet therapy with darolutamide: UK multicenter RECOMMEND study.
2025 · Amit Bahl, Amarnath Challapalli, et al. · Journal of Clinical Oncology · 1
Late toxicity described using patient reported outcomes measures (PROMS) in men treated with salvage radiation following primary high intensity focal ultrasound (HIFU) for localized prostate cancer.
2019 · Reena Davda, Clement Orczyk, et al. · Journal of Clinical Oncology · 1
Radiotherapy in elderly patients with prostate cancer
2018 · Mark Prentice, Amy Lewis, et al. · Trends in Urology & Men s Health · 1
PDF
Toxicity Outcomes in the Elderly Prostate Cancer Patient
2017 · M. Prentice, R. Davda, et al. · Clinical Oncology · 1
Late Toxicity and Patient Reported Outcomes in Patients Treated With Salvage Radiation Following Primary High Intensity Focal Ultrasound for Localized Prostate Cancer
2017 · R. Davda, M. Prentice, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Management of Synchronous Rectal and Prostate Cancer with Radiotherapy - A Single-Centre Case Report
2026 · Melissa Lovegrove, Mark Prentice, et al. · Radiography
IUC26696-94 Enfortumab Vedotin Plus Pembrolizumab Outcomes in Advanced Urothelial Cancer: Real-World Data
2026 · S Peroos, A Saeed, et al. · The Oncologist
PDF
Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort E
2026 · Marinela Augustin, Brigitte Laguerre, et al. · European Urology Oncology
Impact of age, number of cycles of chemotherapy and presence of visceral metastases on PSA response in patients on triplet therapy (ADT + darolutamide + docetaxel) for mHSPC: UK real world data from the RECOMMEND study.
2026 · Amit Bahl, Amarnath Challapalli, et al. · Journal of Clinical Oncology
PDF
P0149 Potential for Drug-Drug Interactions with novel ARTAs and concomitant medications: Analysis based on the Metastatic Hormone Sensitive Prostate Cancer (MHSPC) patients in the Real-World Evidence (RWE) RECOMMEND study
2026 · A. Bahl, A. Challapalli, et al. · European Urology
Stereotactic Ablative Body Radiotherapy (SABR) for localized renal cell carcinoma (RCC) in geriatric patients: A single centre review
2025 · P. Khanal, P. Wylie, et al. · Journal of Geriatric Oncology
2807 Demographic disparities in patients recruited into prostate cancer radiotherapy clinical trials
2025 · Kieran Palmer, Muhammad Rauf, et al. · Radiotherapy and Oncology
Efficacy outcomes 12 months after initiation of darolutamide in non-metastatic castrate resistant prostate cancer (nmCRPC) from the real world UK multi-centre RECORD study.
2025 · Amarnath Challapalli, Amit Bahl, et al. · Journal of Clinical Oncology
PDF
Treatment of macroscopic prostate bed recurrences with a focal dose-escalated boost
2025 · K. Palmer, A. Anderson, et al. · Clinical Oncology
P122 Therapeutic options in metastatic hormone-sensitive prostate cancer stratified by volume and risk – real-world data from a single centre experience
2024 · K. Palmer, A. Robertson, et al. · European Urology Open Science
Radical radiotherapy for muscle-invasive bladder cancer: A single centre experience.
2023 · Mayumi Forster, Ami Mehta, et al. · Journal of Clinical Oncology
PDF
Works count: 38
Citation count: 410
H-index: 5
I10-index: 4
Year
Topic
Type